Status:
COMPLETED
Complete Vocal Technique Voice Therapy for Muscle Tension Dysphonia (CVT4MTD)
Lead Sponsor:
Nottingham University Hospitals NHS Trust
Collaborating Sponsors:
Innovation Fund Denmark
Conditions:
Muscle Tension Dysphonia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This proof-of-concept study is designed to evaluate whether a pedagogic technique used to help performers, known as the Complete Vocal Technique (CVT), can be used to help patients with a type of voic...
Detailed Description
Voice problems (dysphonia) affect one in 13 adults annually, causes a major impact on quality of life and livelihood and is a substantial healthcare burden. It is more common in women and in those wit...
Eligibility Criteria
Inclusion
- Clinical diagnosis of primary Muscle Tension Dysphonia (MTD) based on history and laryngoscopic assessment (Type (I-III) MTD pattern) through joint assessment by a SLT-V and laryngologist
- Current voice problems, persistent for greater than 2 months
- Severity of disorder a) Voice Handicap Index (VHI) ≥ 30 and b) patient wants therapy
- Patient willingness to undergo treatment
- Consent to participate in study protocol
Exclusion
- Organic vocal pathology 1) Structural/neoplastic disorders (e.g. carcinoma, cyst, polyp, papilloma, Reinke's oedema); 2) neurological disorders (e.g. vocal cord palsy, paresis, spasmodic dysphonia); 3) inflammation (e.g. infection, reflux (RFS \>7) or significant relevant systemic disease (e.g. severe Chronic Obstructive Pulmonary Disease) or need for surgery
- Significant psychological issues identified during initial assessment (with option to withdraw if discovered during the treatment periods and agreed by both patient and Therapist)
- MTD pattern (IV-VI) compatible with significant primary psychological aetiology on laryngoscopy
- Transgender voice issues
- Previously incompletely treated dysphonia, neurological disease, or upper aerodigestive tract malignancy Had previous Voice Therapy (VT) or CVT training or pharmacological treatment for their voice problem - (other than proton pump inhibitors or an alginate recommended for disorders of laryngopharyngeal reflux-related symptoms)
- A hearing impairment that would prohibit or impact on telepractice treatment
- Significant concomitant health problems affecting voice
- Not have or be able to use a computer with video link at home or in hospital even with support
Key Trial Info
Start Date :
May 5 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 28 2022
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT05365126
Start Date
May 5 2022
End Date
December 28 2022
Last Update
June 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nottingham University Hospitals NHS Trust
Nottingham, Nottinghamshire, United Kingdom, NG7 2UH